Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
20,49 USD | -1,21% | -8,20% | -5,18% |
Omzet 2024 * | 31,42 mln. 29,52 mln. | Omzet 2025 * | 121 mln. 114 mln. | Marktkapitalisatie | 1,76 mld. 1,66 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -312 mln. -293 mln. | Nettowinst (verlies) 2025 * | -251 mln. -236 mln. | EV/omzet 2024 * | 46,8 x |
Nettoliquiditeiten 2024 * | 291 mln. 274 mln. | Nettoliquiditeiten 2025 * | 223 mln. 209 mln. | EV/omzet 2025 * | 12,7 x |
K/w-verhouding 2024 * |
-5,49
x | K/w-verhouding 2025 * |
-7,42
x | Werknemers | 184 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,15% |
Recentste transcriptie over Syndax Pharmaceuticals, Inc.
1 dag | -1,21% | ||
1 week | -8,20% | ||
Lopende maand | -13,91% | ||
1 maand | -6,52% | ||
3 maanden | -3,85% | ||
6 maanden | +72,33% | ||
Lopend jaar | -5,18% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Metzger
CEO | Chief Executive Officer | 53 | 05-05-15 |
Peter Ordentlich
FOU | Founder | 55 | 11-10-05 |
Neil Gallagher
PSD | President | 60 | 10-04-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Keith Katkin
BRD | Director/Board Member | 52 | 29-03-17 |
Dennis Podlesak
CHM | Chairman | 66 | 01-12-08 |
Pierre Legault
BRD | Director/Board Member | 63 | 04-01-17 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.12% | 0 M€ | 0,00% | - | |
0.12% | 0 M€ | 0,00% | - | |
0.08% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 20,49 | -1,21% | 1 220 776 |
17-04-24 | 20,74 | -2,54% | 1 783 012 |
16-04-24 | 21,28 | -1,57% | 749 097 |
15-04-24 | 21,62 | -0,46% | 1 043 229 |
12-04-24 | 21,72 | -2,69% | 618 727 |
uitgestelde koers Nasdaq, 18 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-5,18% | 1,76 mld. | |
-1,82% | 41,36 mld. | |
+44,25% | 41,3 mld. | |
+2,56% | 39,61 mld. | |
-12,11% | 25,62 mld. | |
+3,09% | 24,09 mld. | |
-24,16% | 18,38 mld. | |
+22,12% | 11,85 mld. | |
-3,74% | 11,82 mld. | |
+7,75% | 11,07 mld. |